← Human Trials & Peer-Reviewed Studies

Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial.

Plain-language guide to PMID 16278262 (2006): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
16278262
Journal
The Journal of clinical endocrinology and metabolism
Year
2006
Study type
Randomized Controlled Trial
Authors
El-Hajj Fuleihan G et al. (9 authors)
DOI
10.1210/jc.2005-1436

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Despite the high prevalence of hypovitaminosis D in children and adolescents worldwide, the impact of vitamin D deficiency on skeletal health is unclear.

Who Took Part

By PubMed's age tags, the people studied were children and teenagers, women only.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

Areal bone mineral density (BMD) and bone mineral content (BMC) at the lumbar spine, hip, forearm, total body, and body composition were measured at baseline and 1 yr.

Serum calcium, phosphorus, alkaline phosphatase, and vitamin D metabolites were measured during the study.

What Was Measured

PubMed files the paper under topics including Alkaline Phosphatase, Body Composition, Bone Density, Calcium, Exercise, Hand Strength and Lebanon.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2006 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.